Bio Nano Consulting completes transition to self-funding organisation

12 Nov 2010

Bio Nano Consulting (BNC), a joint venture of Imperial College and University College London that specialises in bio and nanotechnology  partnerships between the academic and industrial sectors, has completed its publicly funded phase of corporate development.

At the same time, to mark the company’s transition to a self-supporting and revenue-funded organisation, BNC has acquired new expanded offices in central London to meet the increasing demand for its services and specialist expertise.

BNC was formed in 2007 as the UK’s Micro and Nanotechnology Centre focused on bionanotechnology, with funding from the UK Technology Strategy Board (TSB) and the London Development Agency (LDA). The funding provided open access to facilities in BNC’s partner institutions, which is to continue.

Since the company’s launch, Bio Nano Consulting has completed 22 projects for 16 life science and high-technology sector companies. Furthermore, the company already has a further 10 projects actively in progress.

BNC is now partnered with three leading academic institutions, namely Imperial College London, University College London and the School of Pharmacy, University of London. The formation of a fourth, internationally focused partnership is expected to be announced this year.  

CEO Dr David Sarphie commented: “We are pleased to have completed the first phase of our business plan and to have exceeded our growth projections. We have made effective use of TSB and LDA publicly funded resources to help UK and international clients adopt nanotechnology and also to drive the success of Bio Nano Consulting, enabling the company to emerge as a fully self-financed, revenue-driven enterprise.

"We predict continued revenue growth as we confidently embark on the planned second phase in our company’s development. We look forward to servicing the expanding stream of project based clients in international markets, all of whom will continue to benefit from our unique business model that combines strong project management expertise with access to scientists in world leading academic institutions.”